Matching Items (2)
Filtering by

Clear all filters

134647-Thumbnail Image.png
Description
The overall goal of this project is to use metallic nanoparticles to develop a thin, ductile amorphous film at room temperature. Currently bulk metallic glasses are mainly formed via quenching, which requires very high cooling rates to achieve an amorphous molecular structure. These formations often fail in a brittle manner.

The overall goal of this project is to use metallic nanoparticles to develop a thin, ductile amorphous film at room temperature. Currently bulk metallic glasses are mainly formed via quenching, which requires very high cooling rates to achieve an amorphous molecular structure. These formations often fail in a brittle manner. The advantages of using a bottom-up approach with amorphous nanoparticles at ambient conditions is that the ductility of the metal can be improved, and the process will be less energy intensive. The nanoparticles used are iron precursors with ATMP and DTPMP ligand stabilizers and dispersed in methanol. Three forms of experimentation were applied over the course of this project. The first was a simple, preliminary data collection approach where the particles were dispersed onto a glass slide and left to dry under various conditions. The second method was hypersonic particle deposition, which accelerated the particles to high speeds and bombarded onto a glass or silicon substrate. The third method used Langmuir-Blodgett concepts and equipment to make a film. Qualitative analyses were used to determine the efficacy of each approach, including SEM imaging. In the end, none of the approaches proved successful. The first approach showed inconsistencies in the film formation and aggregation of the particles. The results from the hypersonic particle deposition technique showed that not enough particles were deposited to make a consistent film, and many of the particles that were able to be deposited were aggregated. The Langmuir-Blodgett method showed potential, but aggregation of the particles and uneven film formation were challenges here as well. Although there are ways the three discussed experimental approaches could be optimized, the next best step is to try completely new approaches, such as convective assembly and 3D printing to form the ideal nanoparticle film.
ContributorsKline, Katelyn Ann (Author) / Lind, Mary Laura (Thesis director) / Cay, Pinar (Committee member) / Chemical Engineering Program (Contributor) / Barrett, The Honors College (Contributor)
Created2016-12
135508-Thumbnail Image.png
Description
Neurological disorders are difficult to treat with current drug delivery methods due to their inefficiency and the lack of knowledge of the mechanisms behind drug delivery across the blood brain barrier (BBB). Nanoparticles (NPs) are a promising drug delivery method due to their biocompatibility and ability to be modified by

Neurological disorders are difficult to treat with current drug delivery methods due to their inefficiency and the lack of knowledge of the mechanisms behind drug delivery across the blood brain barrier (BBB). Nanoparticles (NPs) are a promising drug delivery method due to their biocompatibility and ability to be modified by cell penetrating peptides, such as transactivating transciptor (TAT) peptide, which has been shown to increase efficiency of delivery. There are multiple proposed mechanisms of TAT-mediated delivery that also have size restrictions on the molecules that can undergo each BBB crossing mechanism. The effect of nanoparticle size on TAT-mediated delivery in vivo is an important aspect to research in order to better understand the delivery mechanisms and to create more efficient NPs. NPs called FluoSpheres are used because they come in defined diameters unlike polymeric NPs that have a broad distribution of diameters. Both modified and unmodified 100nm and 200nm NPs were able to bypass the BBB and were seen in the brain, spinal cord, liver, and spleen using confocal microscopy and a biodistribution study. Statistically significant differences in delivery rate of the different sized NPs or between TAT-modified and unmodified NPs were not found. Therefore in future work a larger range of diameter size will be evaluated. Also the unmodified NPs will be conjugated with scrambled peptide to ensure that both unmodified and TAT-modified NPs are prepared in identical fashion to better understand the role of size on TAT targeting. Although all the NPs were able to bypass the BBB, future work will hopefully provide a better representation of how NP size effects the rate of TAT-mediated delivery to the CNS.
ContributorsCeton, Ricki Ronea (Author) / Stabenfeldt, Sarah (Thesis director) / Sirianni, Rachael (Committee member) / Harrington Bioengineering Program (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05